Founded by research scientists in 1999, Cell Signaling Technology (CST) is a private, family-owned company that prides itself on operating as a research institute developing quality products for other researchers. Active in the field of applied systems biology research, particularly as it relates to cancer, CST understands the importance of using antibodies. That's why all of our antibodies are painstakingly validated for multiple applications by our Ph.D. level scientists. And the same CST scientists who helped produce your antibody will also provide technical support, methods, and guidance needed to achieve the most reliable results. Check out our website! For Research Use Only. Not for Use in Diagnostic Procedures.
Looking for a particular Cell Signaling Technology (CST) employee's phone or email?
Cell Signaling Technology (CST) Questions
The Cell Signaling Technology (CST) annual revenue was $40.1 million in 2026.
Matthew Curran is the Chief Financial Officer and Board Member of Cell Signaling Technology (CST).
600 people are employed at Cell Signaling Technology (CST).
Cell Signaling Technology (CST) is based in Danvers, Massachusetts.
The NAICS codes for Cell Signaling Technology (CST) are [541711, 5417, 541, 54171, 54].
The SIC codes for Cell Signaling Technology (CST) are [873, 87].
Top Cell Signaling Technology (CST) Employees
-
21
-
Harjit Kullar
Senior Vice President, Global Marketing at Cell Signaling Technology (CST)
California, United States25+ -
32
Related Companies
